Green Thumb Industries (GTBIF) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Green Thumb Industries

OTC Markets OTCQX•Healthcare•Drug Manufacturers - Specialty & Generic

$6.56-0.14(-0.02%)Pre-market

Market Cap

$1.43B

P/E

14.5x

P/S

1.2x

P/B

0.8x

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

How this company scores

ExcellentMetricSide Score: 83/100

Strongest: Cash & Earnings Quality (25/25); weakest: Profitability (17/25).

Profitability17/25

Growth21/25

Balance Sheet & Red Flags20/25

Cash & Earnings Quality25/25

Strengths

Rising free cash flowRising earningsLow leverageCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 14.5x5y range 10.7x – 171.1x

Currently below its 17-quarter median.

P/S · 1.2x5y range 1.1x – 5.5x

Currently below its 20-quarter median.

P/B · 0.8x5y range 0.7x – 3.0x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 44.1% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Price & Volume

Market Cap $1.43B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.24B
Q. Revenue: $324.41M
TTM EBITDA: $260.90M
TTM Op. Income: $104.83M
Q. Op. Income: $25.09M
TTM Net Income: $98.65M
Q. Net Income: $-4.83M
EPS: $-0.02
Shares Out.: $218.62M

$1.24B in TTM revenue grew 7.2% YoY, reaching $324.41M last quarter. TTM EBITDA of $260.90M and TTM operating income of $104.83M show growth is flowing through to the bottom line. TTM net income of $98.65M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 45.2%
EBITDA Margin: 18.3%
Op. Margin: 7.7%
Net Margin: -1.5%

Op. margin of 7.7% is down 4.9% YoY — costs are rising relative to revenue. Net margin at -1.5% and gross margin of 45.2% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 39% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 14.5x
P/S Ratio: 1.2x
P/B Ratio: 0.8x

At 14.5x P/E, the stock trades below typical market levels. P/S of 1.2x and P/B of 0.8x provide additional context. P/E sits below typical market levels while revenue is growing. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.85B
Cash: $316.00M
Long-Term Debt: $253.57M
Book Value: $1.86B
D/E Ratio: 0.1
Debt/EBITDA: 4.3

With $2.85B in assets and $253.57M in long-term debt, D/E is 0.1and book value is $1.86B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $58.27M
TTM Free Cash Flow: $179.22M
FCF Margin: 14.4%
FCF / Net Income: 1.8

TTM FCF of $179.22M on $58.27M in operating cash flow. The FCF / Net Income ratio of 1.8x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.